PRISM Study-Pruritus Relief Through Itch Scratch Modulation
Study sponsor: Trevi Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-05-10Actual
Enrollment · participants353Actual
Source updated2025-06-24Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.